As inflammation is a prerequisite to induce immune responses rather than tolerance, it is conceivable that delivery of inflammatory cytokines such as IL-12, IFN-γ to the tumor or its draining lymph node would be helpful to overcome the immunocompromised status in some patients, for example, in cancer patients. Here, IFNG is linked to cancer.